Xin Lang Cai Jing·2026-02-06 10:07Group 1 - The core viewpoint of the news is that Spring Medical has shown significant financial performance with a notable increase in revenue and net profit, indicating strong growth potential in the orthopedic medical device sector [2][3] - As of September 30, 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit of 192 million yuan, with a year-on-year increase of 213.21% [2] - The company has a high financing balance of 47.78 million yuan, which accounts for 0.72% of its market capitalization, indicating a strong interest from investors [1] Group 2 - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company has a diverse export market, with products reaching Asia, South America, Africa, Oceania, and Europe [2] - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2]